173 related articles for article (PubMed ID: 25691053)
1. Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.
Cai L; Li J; Zhang X; Lu Y; Wang J; Lyu X; Chen Y; Liu J; Cai H; Wang Y; Li X
Oncotarget; 2015 Apr; 6(10):7838-50. PubMed ID: 25691053
[TBL] [Abstract][Full Text] [Related]
2. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW
J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
[TBL] [Abstract][Full Text] [Related]
3. Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma.
Wardana T; Gunawan L; Herawati C; Oktriani R; Anwar S; Astuti I; Aryandono T; Mubarika S
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2777-2782. PubMed ID: 32986380
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of the anti-viral interferon lambda 3 as direct target of the Epstein-Barr virus microRNA-BART7-3p.
Blümke J; Bauer M; Vaxevanis C; Wilfer A; Mandelboim O; Wickenhauser C; Seliger B; Jasinski-Bergner S
Oncoimmunology; 2023; 12(1):2284483. PubMed ID: 38126030
[TBL] [Abstract][Full Text] [Related]
5. Plasma Epstein-Barr virus microRNA BART8-3p as a potential biomarker for detection and prognostic prediction in early nasopharyngeal carcinoma.
Lin C; Chen Y; Lin X; Peng H; Huang J; Lin S; Pan J; Li M; Zong J
Sci Rep; 2024 Mar; 14(1):7433. PubMed ID: 38548853
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.
Wu Y; Zhang X; Liu C; Li Z; Wen Y; Zheng R; Xu C; Tian J; Wei L; Wang J; Yan Q; Zheng X; Ma J
J Biol Chem; 2023 Sep; 299(9):105082. PubMed ID: 37495108
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) encoded microRNA BART8-3p drives radioresistance-associated metastasis in nasopharyngeal carcinoma.
Zhou X; Lin Y; Chen Y; Wang L; Peng X; Liao J; Zeng H; Luo W; Wu D; Cai L
J Cell Physiol; 2021 Sep; 236(9):6457-6471. PubMed ID: 33694159
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma.
Mai S; Xiao R; Shi L; Zhou X; Yang T; Zhang M; Weng N; Zhao X; Wang R; Liu J; Sun R; Qin H; Wang H
Cell Death Dis; 2019 Oct; 10(11):819. PubMed ID: 31659158
[TBL] [Abstract][Full Text] [Related]
9. Post cross-linked ROS-responsive poly(β-amino ester)-plasmid polyplex NPs for gene therapy of EBV-associated nasopharyngeal carcinoma.
Yuan C; Chang S; Zhang C; Dong D; Ding J; Mahdavian AR; Hu Z; Sun L; Tan S
J Mater Chem B; 2024 Mar; 12(12):3129-3143. PubMed ID: 38451208
[TBL] [Abstract][Full Text] [Related]
10. Alterations in cellular expression in EBV infected epithelial cell lines and tumors.
Edwards RH; Dekroon R; Raab-Traub N
PLoS Pathog; 2019 Oct; 15(10):e1008071. PubMed ID: 31584998
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-encoded miR-BART11-3p modulates the DUSP6-MAPK axis to promote gastric cancer cell proliferation and metastasis.
Xu M; Lin J; Yang S; Yao J; Chen M; Feng J; Zhang L; Zhou L; Zhang J; Qin Q
J Virol; 2023 Sep; 97(9):e0088123. PubMed ID: 37681959
[TBL] [Abstract][Full Text] [Related]
12. Epstein
Li W; Yi W; Yang D; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 46(3):300-308. PubMed ID: 33927078
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-mediated control of Epstein-Barr virus infection and potential diagnostic and therapeutic implications.
Skalsky RL
Curr Opin Virol; 2022 Oct; 56():101272. PubMed ID: 36242893
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary deregulation of expression of
Ali GE; Ibrahim MA; El-Deeb AH; Amer H; Zaki SM
Int J Nanomedicine; 2019; 14():5569-5579. PubMed ID: 31413563
[No Abstract] [Full Text] [Related]
15. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.
Cai L; Ye Y; Jiang Q; Chen Y; Lyu X; Li J; Wang S; Liu T; Cai H; Yao K; Li JL; Li X
Nat Commun; 2015 Jul; 6():7353. PubMed ID: 26135619
[TBL] [Abstract][Full Text] [Related]
17. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.
Shinozaki-Ushiku A; Kunita A; Isogai M; Hibiya T; Ushiku T; Takada K; Fukayama M
J Virol; 2015 May; 89(10):5581-91. PubMed ID: 25740983
[TBL] [Abstract][Full Text] [Related]
18. Lymphoproliferative disease and cancer among patients with common variable immunodeficiency.
Gangemi S; Allegra A; Musolino C
Leuk Res; 2015 Apr; 39(4):389-96. PubMed ID: 25711943
[TBL] [Abstract][Full Text] [Related]
19. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
Peng X; Cao P; Li J; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Cancer Biol Ther; 2015; 16(2):261-7. PubMed ID: 25756509
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of hepatitis B viral infection in Epstein-Barr virus-associated nasopharyngeal carcinoma.
Xu T; Huang Z; Deng Y; Wang S; Su B; Wei W; Wang D; Jiang J; Li A; Zhang G; Yang H; Claret FX; Hu W
J Clin Virol; 2015 Mar; 64():64-71. PubMed ID: 25728081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
